ATAI Life Sciences N.V. Annual Income Tax Expense (Benefit) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
ATAI Life Sciences N.V. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2020 to 2023.
  • ATAI Life Sciences N.V. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $19K, a 89.7% decline year-over-year.
  • ATAI Life Sciences N.V. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $681K, a 89.5% decline year-over-year.
  • ATAI Life Sciences N.V. annual Income Tax Expense (Benefit) for 2023 was $1.02M, a 83.7% decline from 2022.
  • ATAI Life Sciences N.V. annual Income Tax Expense (Benefit) for 2022 was $6.23M, a 56.2% increase from 2021.
  • ATAI Life Sciences N.V. annual Income Tax Expense (Benefit) for 2021 was $3.99M, a 1208% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.02M -$5.21M -83.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $6.23M +$2.24M +56.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $3.99M +$3.68M +1208% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-24
2020 $305K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.